Approval · Notice of Compliance 1268 · 2000
ZESTORETIC: Notice of Compliance 1268
Issued February 15, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1268
- Date
- February 15, 2000
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Angiotensin converting enzyme inhibitor/diuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZESTORETIC | 02103729 | Marketed |
| ZESTORETIC | 02045737 | Marketed |
| ZESTORETIC | 02045729 | Marketed |
Medicinal ingredients
- HYDROCHLOROTHIAZIDE 12.5 MG per TAB
- LISINOPRIL 10 MG per TAB
- LISINOPRIL 20 MG per TAB
- HYDROCHLOROTHIAZIDE 25 MG per TAB